KENNETH GILLEN: Open Payments
NPI 1225098494 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 33 payments from 11 companies in 2025. Trend: 2023 $1,031 · 2024 $999 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $200 |
| AstraZeneca Pharmaceuticals LP | 3 | $165 |
| Dexcom, Inc. | 3 | $87 |
| Novo Nordisk Inc | 3 | $57 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Daiichi Sankyo Inc. | 2 | $29 |
| PFIZER INC. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: BREZTRI, Dexcom G6 Transmitter, CREON, LINZESS, Rybelsus, INJECTAFER, PREVNAR 20, MAVYRET.
Industry payments across CA — which companies pay providers there.
